2016
DOI: 10.1002/cptx.1
|View full text |Cite
|
Sign up to set email alerts
|

Determination of Metabolic Viability and Cell Mass Using a Tandem Resazurin/Sulforhodamine B Assay

Abstract: The identification of rapid, reliable, and highly reproducible biological assays that can be standardized and routinely used in preclinical tests constitutes a promising approach to reducing drug discovery costs and time. This unit details a tandem, rapid, and reliable cell viability method for preliminary screening of chemical compounds. This assay measures metabolic activity and cell mass in the same cell sample using a dual resazurin/sulforhodamine B assay, eliminating the variation associated with cell see… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
33
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 41 publications
(34 citation statements)
references
References 44 publications
0
33
0
Order By: Relevance
“…The cytotoxicity profile of the compounds under study was evaluated in differentiated SH-SY5Y cells (8,000 cells/well), according the differentiation protocol previously described, and in HepG2 cells (2.5 × 10 4 cells/well), seeded into 96-well plates. Then, the cells were exposed to increased concentrations of the test compounds (1, 10 and 50 μM) in cell culture medium for 24 h in SH-SY5Y cells or 48 h in HepG2 cells and the cytotoxicity was evaluated through measuring changes in cellular metabolic activity using the MTT or resazurin reduction assays, respectively (Silva et al, 2016 ). In both assays, the reduction of MTT tetrazolium salt or resazurin to MTT formazan or resorufin, respectively, by cellular dehydrogenases present in viable cells, gives insights on cell metabolic activity.…”
Section: Methodsmentioning
confidence: 99%
“…The cytotoxicity profile of the compounds under study was evaluated in differentiated SH-SY5Y cells (8,000 cells/well), according the differentiation protocol previously described, and in HepG2 cells (2.5 × 10 4 cells/well), seeded into 96-well plates. Then, the cells were exposed to increased concentrations of the test compounds (1, 10 and 50 μM) in cell culture medium for 24 h in SH-SY5Y cells or 48 h in HepG2 cells and the cytotoxicity was evaluated through measuring changes in cellular metabolic activity using the MTT or resazurin reduction assays, respectively (Silva et al, 2016 ). In both assays, the reduction of MTT tetrazolium salt or resazurin to MTT formazan or resorufin, respectively, by cellular dehydrogenases present in viable cells, gives insights on cell metabolic activity.…”
Section: Methodsmentioning
confidence: 99%
“…Dye bound to cell proteins was extracted with 10 mM Tris-base solution, pH 10. After SRB labeling, absorbance was measured in a Biotek Cytation 3 spectrophotometer at 510 nm with background correction at 620 nm, the amount of dye released is proportional to the number of cell mass in each well, as demonstrated previously (Silva et al, 2016;Vichai and Kirtikara, 2006).…”
Section: Cell Proliferation Measurementmentioning
confidence: 99%
“…After removing the PBS 1Â, 500 ll of resazurin solution (1:1000 dilution in growth medium from a stock solution) was added in each well and incubated for 6 h at 37 C with a 5% CO 2 atmosphere. Resorufin fluorescence was measured in a Biotek Cytation 3 spectrophotometer using excitation wavelength of 540 nm and emission of 590 nm (Silva et al, 2016).…”
Section: Metabolic Activity Determinationmentioning
confidence: 99%
“…After removing the PBS 1×, 100 μL of resazurin solution (1:100 dilution in growth medium from a stock solution) was added to each well and incubated for 4 h at 37°C with a 5% CO 2 atmosphere. Resorufin fluorescence was measured in a BioTek Cytation 3 spectrophotometer using excitation wavelength of 540 nm and emission of 590 nm (Silva et al 2016). The spectral characteristics of DMEM and resazurin and menadione (25 µM) were determined in 96-well plate by BioTek Cytation 3 spectrophotometer using wavelength between 350 and 700 nm (visible spectrum).…”
Section: Journal Of Molecular Endocrinologymentioning
confidence: 99%